ICAM1 and triple-A syndrome: Inhibition of solTNF signaling potentially reduced ICAM1 expression in endothelial cells and thereby leukocyte entry to the damaged aortic wall at the initiation of AAA expansion (days 3–7), which could partly explain the reduced AAA formation in the XPro1595-treated mice.